BSD Medical Reports Publication of Editorial Advocating Hyperthermia Treatment Published in The Lancet Oncology
Saved in:
| Title: | BSD Medical Reports Publication of Editorial Advocating Hyperthermia Treatment Published in The Lancet Oncology |
|---|---|
| Authors: | BSD Medical Corporation |
| Source: | Business Wire (English). 05/28/2014. |
| Abstract: | BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) (www.BSDMedical.com) today announced that an editorial advocating hyperthermia treatment was published in The Lancet Oncology, the premier worldwide journal for original oncology research. The editorial on the evolving role of hyperthermia in cancer therapy was titled “Hyperthermia in cancer: is it coming of age?" [The Lancet Oncol, Vol:15, Issue 6, pages 565-566, May 2014; doi: 10.1016/S1470-2045(14)70207-4.] The editorial was written by Professors Adam Januszewski and Justin Stebbing, Department of Surgery & Cancer, Imperial College London. [ABSTRACT FROM PUBLISHER] |
| Database: | Regional Business News |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) (www.BSDMedical.com) today announced that an editorial advocating hyperthermia treatment was published in The Lancet Oncology, the premier worldwide journal for original oncology research. The editorial on the evolving role of hyperthermia in cancer therapy was titled “Hyperthermia in cancer: is it coming of age?" [The Lancet Oncol, Vol:15, Issue 6, pages 565-566, May 2014; doi: 10.1016/S1470-2045(14)70207-4.] The editorial was written by Professors Adam Januszewski and Justin Stebbing, Department of Surgery & Cancer, Imperial College London. [ABSTRACT FROM PUBLISHER] |
|---|
